(原标题:康方生物临床用药失控背后:累计亏损超20亿元,两款抗癌药逆袭)出品 | 创业最前线作者 | 孟祥娜编辑 | 胡芳洁美编 | 邢静审核 | 颂文近日,重庆巫山县肿瘤患者李某美求医购药的经历,将创新药企康方生物推向舆论的风口浪尖。据大象新闻6月2日报道,李某美经医生推荐,耗费79320元购入卡度尼利单抗注射液,在使用的约70支药物中,仅有6支为正规上市药品、5支标注“慈善基金会捐赠”,其余...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.